ConductScience.org, home

Paper · 185484

Inhibition of actions of glucagon in adipocytes by gastric inhibitory polypeptide.

Dupre J and 4 others. Metabolism, 1976. Cited by 66 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Inhibition of actions of glucagon in adipocytes by gastric inhibitory polypeptide. Papers, record 185484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/185484

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of actions of glucagon in adipocytes by gastric inhibitory polypeptide.
PubMed
Journal
Metabolism
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
66
iCite
Relative citation ratio, by iCite
1.67
iCite
Revised in PubMed
2019-07-25
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dupre JJ
2Greenidge NN
3McDonald TJT J
4Ross SAS A
5Rubinstein DD

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adipose TissueMajor topic
Cyclic AMPMajor topic
Gastric Inhibitory PolypeptideMajor topic
Gastrointestinal HormonesMajor topic
GlucagonMajor topic
Animals
Epididymis
Lipid Metabolism
Male
Rats
Receptors, Cell Surface
Theophylline

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.

PMIDTitleJournalYearIn PapersSource
41,973,737Clinical Potential of GIP in Type 2 Diabetes and Obesity.Diabetes Care2026https://conductscience.org/library/papers/41973737PubMed
32,149,342A compendium of G-protein-coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure.Clin Sci (Lond)2020https://conductscience.org/library/papers/32149342PubMed
22,027,838Transgenic rescue of adipocyte glucose-dependent insulinotropic polypeptide receptor expression restores high fat diet-induced body weight gain.J Biol Chem2011https://conductscience.org/library/papers/22027838PubMed
17,558,485Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets.Diabetologia2007https://conductscience.org/library/papers/17558485PubMed
17,313,320Regulation of lipolysis in adipocytes.Annu Rev Nutr2007https://conductscience.org/library/papers/17313320PubMed
14,708,034Race affects insulin and GLP-1 secretion and response to a long-acting somatostatin analogue in obese adults.Int J Obes Relat Metab Disord2004https://conductscience.org/library/papers/14708034PubMed
6,831,998
Postprandial release of gastric inhibitory polypeptide (GIP) and pancreatic polypeptide in dogs with pancreatic acinar atrophy. Correction of blunted GIP response by addition of pancreatic enzymes to a meal.
Dig Dis Sci1983https://conductscience.org/library/papers/6831998PubMed
3,902,545New developments in the incretin concept.Diabetologia1985https://conductscience.org/library/papers/3902545PubMed
3,516,765Insulin-dependent inhibition of hepatic glycogenolysis by gastric inhibitory polypeptide (GIP) in perfused rat liver.Diabetologia1986https://conductscience.org/library/papers/3516765PubMed
3,082,935Enhancement of insulin action after oral glucose ingestion.J Clin Invest1986https://conductscience.org/library/papers/3082935PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/185484

GET https://conductscience.org/api/papers/v1/185484/authors